Arno Therapeutics, Inc.
30 Two Bridges Road, Suite 270
Fairfield, New Jersey 07004
September 4, 2008
Via Edgar Transmission
Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.W.
Washington, D.C. 20549
| Attention: | Ms. Linda Cvrkel |
Mail Stop 3561
| Re: | Arno Therapeutics, Inc. (the “Company”) Form 10-KSB for the year ended December 31, 2007 File No. 000-52153 |
Dear Ms. Cvrkel:
This shall confirm that the Company has received your letter dated July 21, 2008 containing comments to the Company’s Form 10-KSB for the year ended December 31, 2007. In accordance with the undersigned’s discussions with the Staff, the Company intends to amend the Form 10-KSB, and to provide a written response to such comments, on or before September 12, 2008.
In the meantime, please do not hesitate to contact the undersigned at (862) 703-7175 with any questions.
| Sincerely, | |
| /s/ Brian Lenz | |
| Chief Financial Officer | |
| Arno Therapeutics, Inc. |
| cc: | Mr. Jim Peklenk |
Mr. Christopher J. Melsha, Esq.